The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data.

Key Topics

• Rising Above the Noise: Basing Drug Price on Drug Value
• Analyzing RWE to Best Understand Your Patient Population: Diversity & Inclusion Strategies
• Integrating Data Sources for Optimal Success in Randomized Trials and Real World Evidence
• Navigating the Regulatory Guidelines and Guidance for Optimal Submissions, Approvals, and Outcomes
• Dissecting Causal Inference Utilized for Real World Evidence Generation
• Discussing Tokenization of Clinical Trials for (Long Term) Follow Up of Trial Subjects Using RWD.

Read on marcusevans.com

Companies are choosing to invest heavily to build in-house capabilities to leverage RWE efficiently. But questions remain, especially for organizations that are just beginning to apply RWE. How can RWE be made more accessible to stakeholders across the enterprise? What are the most practical applications of RWE to accelerate research and commercialization? And, how will pharma continue to utilize RWE as an end-to-end capability to improve outcomes and meet business goals? Two pharma giants, Pfizer and Boehringer Ingelheim, have built RWE centers of excellence (CoE), acting as the heart of real-world data (RWD) and RWE for the broader organization. These CoEs house RWE experts and support the clinical and commercial teams to achieve their goals.

Read on xtalks.com

Pharmaceutical companies work with many different types of data ranging from commercial sales through to longitudinal patient data. In this webinar, the featured speakers explore the distinct differences and the importance of applying the right methods to ensure data accuracy and maintain business confidence. The panel of industry and data science experts draw from their collective experiences working with clients and real world datasets across the world. They address some of the most common questions clients ask when working with longitudinal patient data. This webinar will be a discussion on navigating the complexity of real-world data (RWD) to help pharma companies maintain a competitive edge driven through real world insights. The team will provide tips for asking the right analytics questions to unlock the true power of real-world data.

Read on xtalks.com